Starting Clinical Trials: You've Developed Your Product and Protected Your IP, What's Next?

Event Details


August 24, 2011

Add To Calendar



AGG’s Food and Drug Team and Corporate Practice Group invites you to participate in the following complimentary webinar:

“Starting Clinical Trials: You’ve Developed Your Product and Protected Your IP, What’s Next?” being held Wednesday, August 24, 2011 11:30 am – 1:00 pm EDT. In this 90-minute webinar Terrence Gaffney, Partner in the Food and Drug Practice Team will address such issues as:

  • Dealing with the Food and Drug Administration (FDA) in a Pre-Investigational New Drug or Pre-Investigational Device Exemption Meetings
  • Dealing with the Institutional Review Board
  • Preparing for Phase I, II and III trials
  • Working with a Biostatistician
  • Working with the FDA and Clinical Research Organizations (CROs)
  • Entering into agreements with sites, principal investigators, CROs and suppliers
  • Negotiating significant terms of agreements, including obligations and governance, confidentiality and use, record keeping and access, liability and indemnification, ownership of intellectual property and publication rights


  • If you have any questions please contact Tracey Chapman, Event Coordinator at  
  • State Bar of Georiga CLE has been approved for 1.5 hours.